A recent study suggests that individuals who stop using popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Findings released in a major health publication shows that while obese individuals often shed about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"People buying these treatments should be aware of the risk of quick weight regain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to starting weight within about 18 months.
Comparing Treatments
The analysis, which examined 37 of studies involving thousands of patients, contrasted the outcomes of these new drugs with conventional dieting.
Scientists emphasize that people who shed pounds through dieting typically see a less rapid creep back—perhaps 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Experts believe the way of the drugs is key to understanding the heightened rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production might result in the body to produce less of its endogenous GLP-1, and could diminish responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making overeating much more probable."
A Chronic Disease?
Medical guidelines suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts argue that, considering the high risk of relapse, the therapy is often ongoing.
This view is supported by drug manufacturers, who state that the results "underscore the persistent character of excess weight," comparing it to managing diseases like hypertension.
User Accounts
People who have stopped the jabs describe a intense resurgence of hunger.
"It was like a switch activating and you're instantly starving," described one woman.
The struggle is exacerbated if patients have not established permanent lifestyle or habit changes during treatment.
Growing Interest
Figures suggest that millions of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is higher among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- Many access the drugs through private prescriptions rather than the NHS.
Ultimately, researchers emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic cure and long-term success likely depends on combined behavioural support.